1. Home
  2. MRSN vs INUV Comparison

MRSN vs INUV Comparison

Compare MRSN & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • INUV
  • Stock Information
  • Founded
  • MRSN 2001
  • INUV N/A
  • Country
  • MRSN United States
  • INUV United States
  • Employees
  • MRSN N/A
  • INUV N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • INUV Advertising
  • Sector
  • MRSN Health Care
  • INUV Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • INUV Nasdaq
  • Market Cap
  • MRSN 47.1M
  • INUV 52.5M
  • IPO Year
  • MRSN 2017
  • INUV N/A
  • Fundamental
  • Price
  • MRSN $27.87
  • INUV $2.54
  • Analyst Decision
  • MRSN Buy
  • INUV Strong Buy
  • Analyst Count
  • MRSN 5
  • INUV 3
  • Target Price
  • MRSN $30.38
  • INUV $14.00
  • AVG Volume (30 Days)
  • MRSN 211.4K
  • INUV 107.5K
  • Earning Date
  • MRSN 11-14-2025
  • INUV 11-06-2025
  • Dividend Yield
  • MRSN N/A
  • INUV N/A
  • EPS Growth
  • MRSN N/A
  • INUV N/A
  • EPS
  • MRSN N/A
  • INUV N/A
  • Revenue
  • MRSN $33,180,000.00
  • INUV $98,139,861.00
  • Revenue This Year
  • MRSN N/A
  • INUV $25.37
  • Revenue Next Year
  • MRSN N/A
  • INUV $16.24
  • P/E Ratio
  • MRSN N/A
  • INUV N/A
  • Revenue Growth
  • MRSN N/A
  • INUV 25.11
  • 52 Week Low
  • MRSN $5.21
  • INUV $1.90
  • 52 Week High
  • MRSN $70.73
  • INUV $7.90
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 89.87
  • INUV 34.80
  • Support Level
  • MRSN $7.59
  • INUV $2.41
  • Resistance Level
  • MRSN $28.07
  • INUV $2.71
  • Average True Range (ATR)
  • MRSN 0.69
  • INUV 0.20
  • MACD
  • MRSN 1.80
  • INUV -0.00
  • Stochastic Oscillator
  • MRSN 99.51
  • INUV 21.98

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

Share on Social Networks: